Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model
Titel:
Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model
Auteur:
Nshimyumukiza, Léon Duplantie, Julie Gagnon, Mathieu Douville, Xavier Fournier, Diane Lindsay, Carmen Parent, Marc Milot, Alain Giguère, Yves Gagné, Christian Rousseau, François Reinharz, Daniel